Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

NCT02605421 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Thiotepa
DRUG: Cyclophosphamide
DRUG: Melphalan
DRUG: Etoposide
DRUG: Carboplatin
BIOLOGICAL: Autologous Stem Cell Infusion
BIOLOGICAL: Granulocyte colony stimulating factor

Sponsor

Masonic Cancer Center, University of Minnesota